UNAIDS, and ASAP. 2008. “Review of National AIDS Strategic Plan in the Middle East and North Africa.” RST MENA, December. UNAIDS, UNODC (United Nations Office on Drugs and Crime), and WHO (World Health Organization). 2006. “Fact Sheet on Drug Use and HIV in MENA.” November. van Ameijden, E. J., J. K. Watters, J. A. van den Hoek, and R. A. Coutinho. 1995. “Interventions among Injecting Drug Users: Do They Work?” AIDS 9 Suppl A: S75–84. WHO/EMRO (Eastern Mediterranean Regional Office). “Technical Paper on the Regional Strategy for STI Prevention and Control in the Eastern Mediterranean Region of WHO presented at the Regional Committee 55. ———. 2005. “Survey on Status of National AIDS Programme Implementation in the Health Sector.” ——— . 2006 “Progress towards Universal Access to HIV Prevention, Treatment and Care in the Health Sector.” Report on a baseline survey for the year 2005 in the WHO Eastern Mediterranean Region. Draft. ———. 2007. “Progress towards Universal Access to HIV Prevention, Treatment and Care in the Health Sector.”
212
Characterizing the HIV/AIDS Epidemic in the Middle East and North Africa
Report on an indicator survey for the year 2007 in the WHO Eastern Mediterranean Region. ———. 2008a. “Progress towards Universal Access to HIV Prevention, Treatment and Care in the Health Sector. Report on an indicator survey for the year 2007 in the WHO Eastern Mediterranean Region.” ———. 2008b. “Regional Review of HIV Testing and Counseling Policies and Practices in the EMR.” WHO/ EMRO, FHI, unpublished. WHO, UNAIDS, and UNICEF (United Nations Children’s Fund). 2008. “Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector.” Progress report, WHO/UNAIDS/UNICEF, Geneva. World Bank. 2005. “Preventing HIV/AIDS in the Middle East and North Africa: A Window of Opportunity to Act.” Orientations in Development Series, World Bank. Zamani, S., M. Kihara, M. M. Gouya, M. Vazirian, M. Ono-Kihara, E. M. Razzaghi, and S. Ichikawa. 2005. “Prevalence of and Factors Associated with HIV-1 Infection among Drug Users Visiting Treatment Centers in Tehran, Iran.” AIDS 19: 709–16.